The presence of ACPAs can be detected years before the clinical onset of RA [119], and is usually associated with more severe disease outcomes, such as more significant radiologic joint damage, compared to ACPA-negative RA [133,134,135]. Here, PRTN3 is linked to rheumatoid arthritis.